Apr 28, 2023
- Corporate
Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
| Name of listed company: | Chugai Pharmaceutical Co., Ltd. |
| Code number: | 4519 (Prime Market of Tokyo Stock Exchange) |
| Head office: | 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo |
| President & CEO: | Osamu Okuda |
| Inquiries to: | Toshiya Sasai |
| Head of Corporate Communications Dept. | |
| Tel:+81-(0)3-3273-0554 |
TOKYO, April 28, 2023-- Chugai Pharmaceutical Co., Ltd. announced that disposal of treasury shares was completed today, as we announced in the press release “Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan” on March 30, 2023. The result of treasury shares is as follows.
- Overview of Disposal
- Disposal date: April 28, 2023
- Class and number of disposed shares: 125,700 shares of Common stock of the Company
- Disposal price: ¥3,282 per share
- Total value of disposed shares: ¥412,547,400
- Allottees and number thereof; number of disposed shares:
Directors 3 64,000 shares Vice presidents 13 24,500 shares Employees 98 33,900 shares Director of subsidiaries 3 900 shares Employees of subsidiaries 8 2,400 shares
Contact:
- For Media
- Chugai Pharmaceutical Co., Ltd.
- Media Relations Group, Corporate Communications Dept.,
- Toshiya Sasai
- Tel: +81-3-3273-0881
- E-mail: pr@chugai-pharm.co.jp
- For Investors
- Chugai Pharmaceutical Co., Ltd.
- Investor Relations Group, Corporate Communications Dept.,
- Takayuki Sakurai
- Tel: +81-3-3273-0554
- E-mail: ir@chugai-pharm.co.jp
